Stay updated on Pembrolizumab in Recurrent Respiratory Papilloma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Recurrent Respiratory Papilloma Clinical Trial page.

Latest updates to the Pembrolizumab in Recurrent Respiratory Papilloma Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.4.3 was added and revision: v3.4.2 was removed.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedRevision tag updated to v3.4.2 and the older funding-status notice (v3.4.1) was removed. No changes to study details, eligibility criteria, or navigation were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check41 days agoChange Detected- Added a site-wide notice about a lapse in government funding and NIH Clinical Center status with references to cc.nih.gov and opm.gov. Updated the page revision to v3.4.1, replacing the previous v3.4.0.SummaryDifference0.5%

- Check48 days agoChange DetectedFooter and header metadata were updated to include new labels such as 'Last Update Submitted that Met QC Criteria' and 'Last Update Posted', the glossary toggle option, and a revision note 'Revision: v3.4.0'. No changes were made to the study content or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check83 days agoChange DetectedA unified Locations section appears with Illinois and Massachusetts, replacing prior separate location headings. The revision is updated to v3.3.3.SummaryDifference0.4%

- Check112 days agoChange DetectedRevision note updated from v3.2.0 to v3.3.2. There are no user-facing changes to the study details.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Recurrent Respiratory Papilloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Recurrent Respiratory Papilloma Clinical Trial page.